Sol-Gel Technologies (SLGL) Revenue (2018 - 2026)
Sol-Gel Technologies (SLGL) reported Revenue of $108000.0 for Q1 2026, down 89.52% year-over-year from $1.0 million in Q1 2025, and down 84.48% quarter-over-quarter from $696000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Revenue (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 9 years of Revenue data on file, last reported at $108000.0 in Q1 2026.
- Revenue for Q1 2026 came in at $108000.0, down 89.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.5 million (up 52.57% YoY), and the FY2025 annual result was $19.4 million, up 68.04% from the prior year.
- Revenue retreated to $108000.0 in Q1 2026 per SLGL's latest filing, from $696000.0 in the prior quarter.
- Over five years, Revenue peaked at $3.0 billion in Q1 2022 and troughed at $100000.0 in Q4 2022.
- A 5-year average of $202.4 million and a median of $594000.0 in 2023 frame the typical range for Revenue.
- On a YoY basis, Revenue climbed as much as 427860.06% in 2022 and fell as far as 99.52% in 2022.
- A 5-year view of Revenue shows it stood at $100000.0 in 2022, then surged by 347.0% to $447000.0 in 2023, then plunged by 37.81% to $278000.0 in 2024, then surged by 150.36% to $696000.0 in 2025, then sank by 84.48% to $108000.0 in 2026.
- Business Quant data shows SLGL's Revenue at $108000.0 in Q1 2026, $696000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 696,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Dec 31, 2023 | 447,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 594,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 261,000.00 |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | 3.00 Bn |
| Dec 31, 2021 | 20.81 Mn |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 928,000.00 |
| Mar 31, 2021 | 701,000.00 |
| Dec 31, 2020 | 2.06 Mn |